Jan G. J. van de Winkel

E859164

Jan G. J. van de Winkel is a Dutch immunologist and biotech entrepreneur best known as the co-founder and long-time leader of the antibody-focused biotechnology company Genmab.

All labels observed (1)

Label Occurrences
Jan G. J. van de Winkel canonical 2

How this entity was disambiguated

Statements (45)

Predicate Object
instanceOf biotechnology entrepreneur
business executive
human
immunologist
associatedWith antibody-focused biotechnology
oncology drug development
boardMemberOf Genmab NERFINISHED
businessSector immuno-oncology
oncology therapeutics
citizenship Netherlands NERFINISHED
coFounderOf Genmab NERFINISHED
countryOfBusinessActivity Denmark NERFINISHED
Netherlands NERFINISHED
United States NERFINISHED
employer Genmab NERFINISHED
familyName van de Winkel NERFINISHED
fieldOfWork antibody therapeutics
biotechnology
immunology
givenName Jan NERFINISHED
hasAcademicBackgroundIn biomedical sciences
immunology
hasGender male
industry biopharmaceutical industry
biotechnology industry
knownFor co-founding Genmab
leadership of Genmab
languageSpoken Dutch
name Jan G. J. van de Winkel NERFINISHED
nationality Dutch
notableRole long-time leader of Genmab
notableWork development of antibody-based cancer therapies at Genmab
leadership in advancing antibody therapeutics to market
occupation biotech entrepreneur
chief executive officer
immunologist
positionHeld Chief Executive Officer of Genmab
Chief Scientific Officer of Genmab
President and CEO of Genmab
President of Genmab
researchInterest antibody engineering
cancer immunotherapy
immune effector mechanisms
monoclonal antibodies
therapeutic antibodies

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Genmab foundedBy Jan G. J. van de Winkel
Genmab hasCEO Jan G. J. van de Winkel